Peak Pharmaceuticals, Inc. Stock Price - PKPH

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
Ultimate Trader (Monthly)
Monthly Subscription
for only
$72.99
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Peak Pharmaceuticals, Inc. (PN) PKPH Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0 +0% 0.0328 - - - 0.0328 08:18:02
Bid Price Ask Price Spread Spread % News
0.032 0.0395 0.0075 18.99% - -
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Peak Pharmaceuticals, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.57M 78.36M $ -2.31M - -1.11 25.88M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.29k 0.00% $ - 0.00% - -

more financials information »

Peak Pharmaceuticals, Inc. (PN) News

Latest PKPH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PKPH Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0399460.040.03130.03599k36k17k-0.007146-17.89%
1 Month0.03060.0430.030.03611k113k33k0.00227.19%
3 Months0.0530.05750.030.03770113k29k-0.0202-38.11%
6 Months0.09380.10.030.06140466k62k-0.061-65.03%
1 Year0.0180.140.01720.059701M97k0.014882.22%
3 Years0.1820.7450.0110.100701M69k-0.1492-81.98%
5 Years0.1820.7450.0110.100701M69k-0.1492-81.98%

Peak Pharmaceuticals, Inc. (PN) Description

Peak Pharmaceuticals, Inc. ("Peak Pharma") specializes in the development, manufacturing, sales and marketing of pharmaceutical-grade, hemp-based nutraceutical and supplement products for the human and animal health markets. Peak Pharma is positioned to develop and market cannabinoid ("CBD") products and to gain a significant share of the immensely attractive and rapidly growing medicinal CBD and hemp markets.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.